WEVAX

 

Eligible Health Care Workers include any regulated health professionals and any staff member, contract worker, student/trainee, registered volunteer, or essential caregiver currently working in-person in a health care organization, including workers that are not providing direct patient and care and are frequently in the patient environment (i.e., cleaning staff, research staff, and other administrative staff).

Workers providing health care service or direct patient service in a congregate, residential, or community setting outside of a health care organization are also eligible.

If you identify as an Indigenous person or live with an individual who identifies as Indigenous, are 16 years of age or older, and received your second dose at least 6 months ago (168 days), please call 226-773-2200 to schedule a vaccination appointment at the mass vaccination site. Booking through phone is available from 8 a.m. to 8 p.m. Monday - Friday, 8 a.m. to 4 p.m. Saturday - Sunday.

Individuals who received two doses of the AstraZeneca vaccine or one dose of the Janssen (Johnson & Johnson) vaccine will receive an mRNA COVID-19 vaccine as their third dose.

If you received the Janssen (Johnson & Johnson) vaccine at least 6 months ago (168 days), please call 226-773-2200 to schedule a vaccination appointment at the mass vaccination site. Booking through phone is available from 8 a.m. to 8 p.m. Monday - Friday, 8 a.m. to 4 p.m. Saturday - Sunday.

Based on Third Dose Recommendations from the Ministry of Health, the following individuals are eligible to receive their third dose:

• Individuals receiving dialysis (hemodialysis or peritoneal dialysis).
• Individuals receiving active treatment (e.g., chemotherapy, targeted therapies, immunotherapy) for solid tumour or hematologic malignancies.
• Recipients of solid-organ transplant and taking immunosuppressive therapy
• Recipients of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy).
• Individuals with moderate to severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome).
• Individuals with stage 3 or advanced untreated HIV infection and those with acquired immunodeficiency syndrome.
• Individuals receiving active treatment with the following categories of immunosuppressive therapies: anti-B cell therapies2 (monoclonal antibodies targeting CD19, CD20 and CD22), high-dose systemic corticosteroids (refer to the CIG for suggested definition of high dose steroids), alkylating agents, antimetabolites, or tumor-necrosis factor (TNF) inhibitors and other biologic agents that are significantly immunosuppressive (see Table 1 in the Ministry of Health Third Dose Recommendations Guidance Document for the list of immunosuppressant medications for third doses).

Booking Information

Your third dose must occur at least two months (8 weeks) after your second dose. In order to optimize the immune response from the vaccine series and minimize delays in the management of their underlying condition, individuals should consult with their health care provider beforehand to determine the exact timing of their vaccination.

Those uncertain about their eligibility should contact their health care provider prior to scheduling a vaccination appointment.

Individuals who receive hematopoietic stem cell transplants (HSCT), hematopoietic cell transplants (HCT) (autologous or allogeneic), and recipients of CAR-T-cell therapy are eligible to re-vaccinate with a new COVID-19 vaccine primary series post-transplantation. All individuals in this category should schedule their appointment as if it is a third dose, even if they have already received a booster dose.

To schedule a vaccination appointment at the mass vaccination site, please call 226-773-2200, available from 8 a.m. to 8 p.m. Monday - Friday, 8 a.m. to 4 p.m. Saturday - Sunday.